125 related articles for article (PubMed ID: 7173627)
21. Brain tumor uptake of iodo-alpha-methyl-tyrosine.
Ell PJ
J Nucl Med; 1991 Nov; 32(11):2193-4. PubMed ID: 1941158
[No Abstract] [Full Text] [Related]
22. 51Cr-bleomycin in the diagnosis of ocular melanoma.
Liniecki J; Pertyński T; Krawczykowa Z; Stepień J; Durski K
Nuklearmedizin; 1983 Dec; 22(6):306-8. PubMed ID: 6199747
[TBL] [Abstract][Full Text] [Related]
23. Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.
Lahoutte T; Caveliers V; Franken PR; Bossuyt A; Mertens J; Everaert H
J Nucl Med; 2002 Sep; 43(9):1201-6. PubMed ID: 12215559
[TBL] [Abstract][Full Text] [Related]
24. [Uptake of DL-3-123I-iodo-alpha-methyltyrosine in recurrent brain tumors].
Guth-Tougelidis B; Müller S; Mehdorn MM; Knust EJ; Dutschka K; Reiners C
Nuklearmedizin; 1995 Apr; 34(2):71-5. PubMed ID: 7761277
[TBL] [Abstract][Full Text] [Related]
25. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
[TBL] [Abstract][Full Text] [Related]
26. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
Samnick S; Richter S; Romeike BF; Heimann A; Feiden W; Kempski O; Kirsch CM
Eur J Nucl Med; 2000 Oct; 27(10):1543-51. PubMed ID: 11083545
[TBL] [Abstract][Full Text] [Related]
27. Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity.
Jager PL; Plaat BE; de Vries EG; Molenaar WM; Vaalburg W; Piers DA; Hoekstra HJ
Clin Cancer Res; 2000 Jun; 6(6):2252-9. PubMed ID: 10873075
[TBL] [Abstract][Full Text] [Related]
28. In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport.
Lahoutte T; Caveliers V; Dierickx L; Vekeman M; Everaert H; Mertens J; Bossuyt A
Nucl Med Biol; 2001 Feb; 28(2):129-34. PubMed ID: 11295423
[TBL] [Abstract][Full Text] [Related]
29. Sequential scintigraphic strategy for the differentiation of brain tumours.
Matheja P; Rickert C; Weckesser M; Palkovic S; Löttgen J; Riemann B; Kopka K; Kuwert T; Wassmann H; Paulus W; Schober O
Eur J Nucl Med; 2000 May; 27(5):550-8. PubMed ID: 10853811
[TBL] [Abstract][Full Text] [Related]
30. Characterization of 3-[123I]iodo-L-alpha-methyl tyrosine ([123I]IMT) transport into human Ewing's sarcoma cells in vitro.
Franzius C; Kopka K; van Valen F; Eckervogt V; Riemann B; Sciuk J; Schober O
Nucl Med Biol; 2001 Feb; 28(2):123-8. PubMed ID: 11295422
[TBL] [Abstract][Full Text] [Related]
31. 123I metaiodobenzylguanidine (MIBG) scintigraphy of retinoblastoma: preliminary experience.
Bomanji J; Hungerford JL; Kingston JE; Levison DA; Britton KE
Br J Ophthalmol; 1989 Feb; 73(2):146-50. PubMed ID: 2930761
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostics of intraocular tumors with the radiophosphorus test (author's transl)].
Schmitt EJ
Klin Monbl Augenheilkd; 1979 Mar; 174(3):408-10. PubMed ID: 480812
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
[TBL] [Abstract][Full Text] [Related]
34. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).
Michelot JM; Moreau MF; Veyre AJ; Bonafous JF; Bacin FJ; Madelmont JC; Bussiere F; Souteyrand PA; Mauclaire LP; Chossat FM
J Nucl Med; 1993 Aug; 34(8):1260-6. PubMed ID: 8326382
[TBL] [Abstract][Full Text] [Related]
35. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
Schmidt D; Langen KJ; Herzog H; Wirths J; Holschbach M; Kiwit JC; Ziemons K; Coenen HH; Müller-Gärtner H
Eur J Nucl Med; 1997 Sep; 24(9):1162-6. PubMed ID: 9283111
[TBL] [Abstract][Full Text] [Related]
36. N-(2-diethylaminoethyl)-4-[123I]iodobenzamide as a tracer for the detection of malignant melanoma: simple synthesis, improved labelling technique and first clinical results.
Brandau W; Kirchner B; Bartenstein P; Sciuk J; Kamanabrou D; Schober O
Eur J Nucl Med; 1993 Mar; 20(3):238-43. PubMed ID: 8462613
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of ocular tumors with technetium-99m-MIBI: planar pinhole technique or SPECT?
Alonso O; Núñez M; Cánepa J; Guisoli P; Mut F; Lago G; Touya E
J Nucl Med Technol; 2000 Jun; 28(2):85-7. PubMed ID: 10824618
[TBL] [Abstract][Full Text] [Related]
38. Accumulation of radioiodinated L-alpha-methyltyrosine in pancreas of mice: concise communication.
Tisljar U; Kloster G; Ritzl F; Stöcklin G
J Nucl Med; 1979 Sep; 20(9):973-6. PubMed ID: 536844
[TBL] [Abstract][Full Text] [Related]
39. Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.
Everaert H; Bossuyt A; Flamen P; Mertens J; Franken PR
J Nucl Med; 1997 Jun; 38(6):870-3. PubMed ID: 9189131
[TBL] [Abstract][Full Text] [Related]
40. Gallium-67 citrate in the detection of ocular malignant melanoma.
Camps JA; Oosterhuis JA; van Langevelde A; Pauwels EK; Stijnen T
Nucl Med Commun; 1987 Jan; 8(1):62. PubMed ID: 3472128
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
